61 related articles for article (PubMed ID: 2986251)
1. Captopril-induced hyperreninemia in cholesterol-fed rabbits.
Overturf ML; Sybers HD; Smith SA
Res Commun Chem Pathol Pharmacol; 1985 Feb; 47(2):229-53. PubMed ID: 2986251
[TBL] [Abstract][Full Text] [Related]
2. Capoten-induced juxtaglomerular hyperplasia in rabbits.
Overturf ML; Sybers HD; Druilhet RE; Smith SA; Kirkendall WM
Res Commun Chem Pathol Pharmacol; 1982 Apr; 36(1):169-72. PubMed ID: 7043682
[TBL] [Abstract][Full Text] [Related]
3. Failure of nifedipine to reduce atherogenesis in cholesterol-fed rabbits.
Overturf ML; Smith SA
Artery; 1986; 13(5):267-82. PubMed ID: 3527114
[TBL] [Abstract][Full Text] [Related]
4. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
Bing RF; Russell GI; Swales JD; Thurston H
J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
[TBL] [Abstract][Full Text] [Related]
5. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
6. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
[TBL] [Abstract][Full Text] [Related]
8. Chronic captopril infusion in two-kidney, one clip rats with normal plasma renin concentration.
Wallace EC; Morton JJ
J Hypertens; 1984 Jun; 2(3):285-9. PubMed ID: 6099389
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin converting enzyme inhibitors and atherosclerosis.
Andersson RG; Jacobsson L; Persson K
J Physiol Pharmacol; 1994 Mar; 45(1):13-25. PubMed ID: 8043902
[TBL] [Abstract][Full Text] [Related]
10. Hyperplasia of juxtaglomerular cells and renin localization in kidney of normotensive animals given captopril. Electron microscopic and immunohistochemical studies.
Zaki FG; Keim GR; Takii Y; Inagami T
Ann Clin Lab Sci; 1982; 12(3):200-15. PubMed ID: 7046618
[TBL] [Abstract][Full Text] [Related]
11. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
12. Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits.
Chen X; Pitt BR; Moalli R; Gillis CN
J Pharmacol Exp Ther; 1984 Jun; 229(3):649-53. PubMed ID: 6327968
[TBL] [Abstract][Full Text] [Related]
13. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
Windt WA; Prakash J; Kok RJ; Moolenaar F; Kluppel CA; de Zeeuw D; van Dokkum RP; Henning RH
J Renin Angiotensin Aldosterone Syst; 2004 Dec; 5(4):197-202. PubMed ID: 15803438
[TBL] [Abstract][Full Text] [Related]
14. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
[TBL] [Abstract][Full Text] [Related]
15. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
[TBL] [Abstract][Full Text] [Related]
16. Low birth weight in response to salt restriction during pregnancy is not due to alterations in uterine-placental blood flow or the placental and peripheral renin-angiotensin system.
Leandro SM; Furukawa LN; Shimizu MH; Casarini DE; Seguro AC; Patriarca G; Coelho MS; Dolnikoff MS; Heimann JC
Physiol Behav; 2008 Sep; 95(1-2):145-51. PubMed ID: 18572207
[TBL] [Abstract][Full Text] [Related]
17. Renin as a risk factor for atherogenesis. Part 2. Effects of hypercholesterolemia and hyporeninemia in the rabbit.
Overturf ML; Sybers HD; Druilhet RE; Kirkendall WM
Atherosclerosis; 1981; 40(3-4):203-22. PubMed ID: 7037015
[TBL] [Abstract][Full Text] [Related]
18. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
19. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system.
Santucci A; Aguglia F; De Mattia G; Cammarella I; Giordano M; Gnecchi M; Trinchieri F; Ficara C
Int J Clin Pharmacol Res; 1984; 4(1):41-5. PubMed ID: 6381343
[TBL] [Abstract][Full Text] [Related]
20. C3 deposition in cholesterol-induced atherosclerosis in rabbits: a possible etiologic role for complement in atherogenesis.
Pang AS; Katz A; Minta JO
J Immunol; 1979 Sep; 123(3):1117-22. PubMed ID: 381517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
